GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Ladprao General Hospital PCL LPH.BK · THB

Health Care · SET · 🇹🇭 Thailand

Compare

3.60

+0.56%

Close of 9 Nov 2026, in THB

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Ladprao General Hospital PCL

Its shares trade on SET under the ticker LPH.BK. It has been listed since 28 October 2015. In the fiscal year to 31 December 2025, it reported revenue of THB 2.59bn and net income of THB 196.6m. At that date it held total assets of THB 2.94bn and shareholders' equity of THB 1.96bn.

Ladprao General Hospital Public Co. Ltd. engages in the provision of healthcare services and medical services for inpatient, outpatient, and emergency patients. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2015-10-28. The firm is engaged in a private hospital business in Bangkok on Ladprao Road by providing general medical treatment services and serving as a center for various medical specializations. The company operates through two segments: Hospital, and Scientific Laboratory Testing & Research. The Hospital segment includes hospital services, health care centers, and service contracts with social security office. The Scientific Laboratory Testing & Research segment offers scientific analytical and diagnostic services for food and agricultural, pharmaceutical, environmental covering product analysis, calibration of instruments and inspections. Its subsidiaries include Ladprao Health and Medical Product Co., Ltd., Asia Medical and Agricultural Laboratory and Research Center Public Company Limited, Asia Business Management Center Co, Ltd., LP Medical Center Co., Ltd. and others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
28 Oct 2015
Employees
714

Leadership

Pay as last reported

  • Prof. Dr. Somsak LohlekhaNon-Executive Chairman of the Board, since 1992THB 550,000
  • Dr. Ungoon ChantanavanichChief Executive Officer, Executive Director, since 1990THB 1.9m
  • Mr. Pipat SavetvilasNon-Executive Vice Chairman of the Board, since 1990THB 480,000
  • Ms. Jirawan MenghongManaging Director
  • Mr. Vitavas PirmpholDeputy Managing Director, Company Secretary
  • Ms. Chomsri ChaiwachirasakDeputy Managing Director - Finance and Account
  • Mr. Ruengrit HassakulMedical Department Administrator
  • Dr. Pramote PhunapanonHospital Director
  • Dr. Sawanan WatcharawanichMedical Department Administrator and Quality Center
  • Mrs. Vidchuda AmpornpholNon-Executive DirectorTHB 400,000
  • Dr. Somchao TanterdthamNon-Executive DirectorTHB 400,000
  • Assoc. Prof. Dr. Wirat WongsangnakNon-Executive Director, since 1992THB 400,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Ladprao General Hospital PCL provides healthcare services in Bangkok with 714 employees.
  • The Hospital segment serves inpatient, outpatient, and emergency patients effectively.
  • Scientific Laboratory Testing & Research segment covers food, pharmaceutical, and environmental analysis.

Weaknesses

  • Ladprao General Hospital PCL operates only in Bangkok city.
  • The company has no international presence beyond Thailand.
  • Ladprao General Hospital PCL's IPO was in 2015, not recent.

Opportunities

  • Expanding Hospital segment to other Thai cities like Chiang Mai.
  • Increasing Scientific Laboratory Testing & Research for pharmaceuticals in Thailand.
  • Ladprao Health and Medical Product Co., Ltd. can grow in medical supplies.

Threats

  • Competition from other Bangkok hospitals in Thailand.
  • New regulations in Thai healthcare sector could affect operations.
  • Ladprao General Hospital PCL's reliance on Bangkok market limits growth.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.